Atara Biotherapeutics (ATRA) Change in Inventory (2022 - 2025)

Atara Biotherapeutics has reported Change in Inventory for 4 years, with the latest figure at -$10.7 million in Q1 2025.

• For the quarter ending Q1 2025, Change in Inventory fell 267.06% year-over-year to -$10.7 million; the trailing twelve-month figure through Dec 2025 stood at -$10.7 million (down 340.3% YoY), and the FY2025 full-year result was -$10.7 million, down 340.3% from the prior year.
• Change in Inventory for Q1 2025 stood at -$10.7 million, down from $160000.0 in the prior quarter.
• The five-year high for Change in Inventory was $6.4 million in Q1 2024, with the low at -$10.7 million in Q1 2025.
• Historically, Change in Inventory has averaged $348500.0 across 4 years, with a median of $2.1 million in 2022.
• Annual changes were most pronounced in 2023 — Change in Inventory soared 96.41% — and 2024, when it slumped 275.51%.
• Atara Biotherapeutics' Change in Inventory stood at $1.6 million in 2022, then soared by 96.41% to $3.1 million in 2023, then slumped by 94.86% to $160000.0 in 2024, then plunged by 6759.38% to -$10.7 million in 2025.
• The last three Change in Inventory figures came in at -$10.7 million (Q1 2025), $160000.0 (Q4 2024), and -$4.8 million (Q3 2024), per Business Quant data.